A RCT of UBE vs. MIS-TLIF in Lumbar Spondylolisthesis

Status Not yet recruiting

Clinical Trial Summary

Unilateral biportal endoscopy (UBE) is a new spinal minimally invasive technique improved for the treatment of lumbar spondylolisthesis (LSP). The present study aims to establish a multicenter, large sample, randomized controlled study to explore the technical advantages and surgical indications of this new technique in the treatment of LSP by comparing with the classical minimally invasive posterior spinal interbody fusion; to compare the postoperative clinical and imaging results and analyze the surgical complications and preventive measures.

Clinical Trial Description

Lumbar spondylolisthesis (LSP) is the most common degenerative lumbar disease in the elderly, and the severe patients need surgical treatment. The elderly are often complicated with many medical diseases and the perioperative risk is high, so minimally invasive surgery is a new direction for spinal surgeons to treat LSP. Unilateral biportal endoscopy (UBE) is a new spinal minimally invasive technique improved. The results of pilot studies showed that it had the advantages of less traumas, fewer complications, quicker recover，and the clinical and imaging outcome was remarkable. Therefore, the present study aims to establish a multicenter, large sample, randomized controlled study to explore the technical advantages and surgical indications of this new technique in the treatment of LSP by comparing with the classical minimally invasive posterior spinal interbody fusion; (2) to compare the postoperative clinical and imaging results and analyze the surgical complications and preventive measures; (3) to establish two-year follow-up to further quantify the clinical and imaging outcome of UBE. Therefore, the present study will further verify and quantify the safety and effectiveness of the UBE in the treatment of LSP on the basis of previous studies, and provide a new clinical approach for minimally invasive treatment of LSP. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05480267
Study type	Interventional
Source	Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact	Zhi-wei WANG, Ph.D and MD.
Phone	0571-87783759
Email	keyanlunli_zheer@163.com
Status	Not yet recruiting
Phase	N/A
Start date	September 1, 2022
Completion date	September 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05527145` - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial	N/A
Not yet recruiting	`NCT03271060` - Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis	N/A
Terminated	`NCT03570801` - SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion	N/A
Recruiting	`NCT05023733` - Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular Implant
Recruiting	`NCT02972190` - Clinical Study of Bilateral Decompression With Interbody Fusion for Spondylolisthesis	N/A
Completed	`NCT04520334` - A Zhineng Qigong Intervention for Patients With Chronic Low Back Pain and/or Leg Pain	N/A
Recruiting	`NCT05405374` - OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study	N/A
Not yet recruiting	`NCT05464134` - Incidence of Lumbar Spondylolisthesis in Patients Candidate for TKR
Completed	`NCT03327298` - Free Hand Lumbar Pedicular Screw Fixation	N/A
Recruiting	`NCT06154005` - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion	Phase 1/Phase 2
Not yet recruiting	`NCT06255366` - Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion	Phase 4
Active, not recruiting	`NCT03733626` - Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease	N/A
Active, not recruiting	`NCT05993195` - Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
Active, not recruiting	`NCT03879447` - Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/Spondylolisthesis
Not yet recruiting	`NCT05691062` - Titanium vs. PEEK Fusion Devices in 1 Level TLIF	Phase 4
Completed	`NCT05345249` - Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery	Phase 4
Completed	`NCT05959343` - Enhanced Recovery After Surgery in Oblique Lumbar Interbody Fusion	N/A
Recruiting	`NCT03745040` - Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion	Phase 4
Recruiting	`NCT03969602` - Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing	N/A
Completed	`NCT04886557` - Retrospective Image Analysis of Degenerative Lumbar Disease Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.